Low-dose radiotherapy combined with immunotherapy eradicates metastatic cancer in mice
Bioengineer
JULY 15, 2021
“We’re excited–with such low doses of radiation, we didn’t expect the response to be so positive,” said lead author Ravi Patel, M.D., In addition to the mouse studies, the physician-scientists worked together with David Vail, D.V.M., This agent was developed by one of the co-authors, Jamey Weichert, Ph.D.,
52 
Let's personalize your content